"Trojan Horse" DNA Nanostructure for Personalized Theranostic: Can It Knock on the Door of Pre-Clinical Practice?

Yuan Li,Sheng Yang,Jing Zheng,Zhen Zou,Ronghua Yang,Weihong Tan
DOI: https://doi.org/10.1021/acs.langmuir.8b02008
IF: 3.9
2018-01-01
Langmuir
Abstract:Nanotheranostics, combing diagnostic and therapeutic components in an all-in-one nanomaterial, possess exciting potentials for precision nanomedicine. However, a major obstacle for current nanotheranostics to enter preclinical and/or clinical trials is the intrinsic toxicities of these nanomaterials. As an emerging biomaterial, the bioinspired DNA nanostructure shows advantages for constructing better nanotheranostics due to its excellent features, including native biocompatibility, full programmability, and ready accessibility. In this feature article, we highlight recent advances in the design of DNA-nanostructure-based diagnostics and/or therapeutics capable of specifically responding to biological stimuli in a dynamic way, with a particular focus on the design mechanism, responsive performance, and potential for preclinical and/or clinical trials in personalized theranostics.
What problem does this paper attempt to address?